The United States: Pharmaceutical Advertising Q&A
July 22, 2020
Andrew Lustigman, Safia Anand and Morgan Spina
The Legal 500
Olshan Advertising & Marketing attorneys have authored a comprehensive Q&A, published by The Legal 500, which can be used as a general key to the legal framework and issues that surround the pharmaceutical advertising law in the United States. The attorneys that contributed to this Q&A include the Chair of Advertising, Marketing and Promotions Group Andrew Lustigman and attorneys, Safia Anand, and Morgan Spina.